Literature DB >> 25815299

Rate of early onset Alzheimer's disease: a systematic review and meta-analysis.

Xi-Chen Zhu1, Lan Tan1, Hui-Fu Wang1, Teng Jiang1, Lei Cao1, Chong Wang1, Jun Wang1, Chen-Chen Tan1, Xiang-Fei Meng1, Jin-Tai Yu1.   

Abstract

It is generally accepted that the population rate of early onset Alzheimer's disease (EOAD) in Alzheimer's disease (AD) is 1-2%. However, the true population based rate of EOAD has never been verified by a systematic review and meta-analysis. We used electronic searches of Cochrane Library, Embase, Medline and PubMed databases to identify published related studies. The systematic review and meta-analysis was then to be conducted to calculate a pooled rate of EOAD and make comparisons between studies and geographic distribution. A total of 13 papers were included in our systematic review and meta-analysis. The rate of EOAD, 5.5% [95% confidence interval (CI): 0.039-0.079, P<0.001], was generated after pooled analysis of all studies in random effect model. The pooled analysis of the rate in developed country was 5.9% (95% CI: 0.040-0.085, P<0.001). The pooled analysis of the rate in developing countries was 4.4% (95% CI: 0.028-0.066, P<0.001). Our study showed that the rate of EOAD in AD is 5.5%, not 1-2% as usually demonstrated. And our results indicated that the rate in developed countries was relative higher than in developing countries. Further trials with larger samples across more countries and more careful designed of experiments are required to confirm whether our findings are truly significant.

Entities:  

Keywords:  Alzheimer’s disease (AD); Early onset Alzheimer’s disease (EOAD); meta-analysis; rate

Year:  2015        PMID: 25815299      PMCID: PMC4356853          DOI: 10.3978/j.issn.2305-5839.2015.01.19

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  28 in total

1.  ICD-9-CM. International Classification of Diseases, 9th revision, Clinical Modification. 3d edition, volumes 1, 2 and 3. Official authorized addendum effective October 1, 1990--HCFA.

Authors: 
Journal:  J Am Med Rec Assoc       Date:  1990-08

Review 2.  Novel disease-modifying therapies for Alzheimer's disease.

Authors:  Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease.

Authors:  O L Lopez; A A Swihart; J T Becker; O M Reinmuth; C F Reynolds; D L Rezek; F L Daly
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

Review 4.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

5.  Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.

Authors:  Lieke L Smits; Yolande A L Pijnenburg; Esther L G E Koedam; Annelies E van der Vlies; Ilona E W Reuling; Teddy Koene; Charlotte E Teunissen; Philip Scheltens; Wiesje M van der Flier
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Severe dementia. Prevalence and clinical features in a biracial US population.

Authors:  B S Schoenberg; D W Anderson; A F Haerer
Journal:  Arch Neurol       Date:  1985-08

7.  Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu.

Authors:  Zhen-Xin Zhang; Gwendolyn E P Zahner; Gustavo C Román; Jun Liu; Zhen Hong; Qiu-Ming Qu; Xie-He Liu; Xiao-Jun Zhang; Bing Zhou; Cheng-Bing Wu; Mao-Ni Tang; Xia Hong; Hui Li
Journal:  Arch Neurol       Date:  2005-03

8.  Incidence of Alzheimer's disease in a rural community in India: the Indo-US study.

Authors:  V Chandra; R Pandav; H H Dodge; J M Johnston; S H Belle; S T DeKosky; M Ganguli
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

9.  Prevalence of age-associated memory impairment and dementia in a rural community.

Authors:  F Coria; J A Gomez de Caso; L Minguez; F Rodriguez-Artalejo; L E Claveria
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

10.  Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.

Authors:  Celeste Sassi; Rita Guerreiro; Raphael Gibbs; Jinhui Ding; Michelle K Lupton; Claire Troakes; Katie Lunnon; Safa Al-Sarraj; Kristelle S Brown; Chirstopher Medway; Jenny Lord; James Turton; David Mann; Julie Snowden; David Neary; Jeniffer Harris; Jose Bras; Kevin Morgan; John F Powell; Andrew Singleton; John Hardy
Journal:  Neurobiol Aging       Date:  2014-05-02       Impact factor: 4.673

View more
  46 in total

1.  Erratum to Rate of early onset Alzheimer's disease: a systematic review and meta-analysis.

Authors: 
Journal:  Ann Transl Med       Date:  2016-05

2.  Genetic Risks for Chronic Conditions: Implications for Long-term Wellbeing.

Authors:  George L Wehby; Benjamin W Domingue; Fredric D Wolinsky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-14       Impact factor: 6.053

Review 3.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

Review 4.  The basis of cellular and regional vulnerability in Alzheimer's disease.

Authors:  Dunja Mrdjen; Edward J Fox; Syed A Bukhari; Kathleen S Montine; Sean C Bendall; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2019-08-07       Impact factor: 17.088

Review 5.  Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine.

Authors:  Aseel Eid; Isha Mhatre; Jason R Richardson
Journal:  Pharmacol Ther       Date:  2019-03-12       Impact factor: 12.310

Review 6.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 7.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 8.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

9.  Prevalence of Traumatic Brain Injury in Early Versus Late-Onset Alzheimer's Disease.

Authors:  Mario F Mendez; Pongsatorn Paholpak; Andrew Lin; Jeannie Y Zhang; Edmond Teng
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

10.  Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity.

Authors:  Meredith L Phillips; Eddie C Stage; Kathleen A Lane; Sujuan Gao; Shannon L Risacher; Naira Goukasian; Andrew J Saykin; Maria C Carrillo; Bradford C Dickerson; Gil D Rabinovici; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2020-01-03       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.